This is a narrative review (no new experiments) synthesizing ~144 references on how lamins behave from NEBD to NE reformation . The core synthesis is well-supported: (1) NEBD involves microtubule-driven tearing plus phosphorylation of lamins flanking the rod domain, dissolving head-to-tail polymer interactions ; (2) B-type lamins (B1/B2) co-localize with spindle microtubules, and their depletion causes spindle asymmetry and aneuploidy; (3) lamin A stays largely soluble via LAP2α and is incorporated into the NE only in late telophase, a timing asymmetry the authors frame as non-redundant lamin function.
Strengths: balanced coverage across species (mammalian cells, Xenopus, C. elegans, Drosophila), explicit acknowledgment of gaps (e.g., lamin B1 disassembly incompletely blocked by CDK1+PKC inhibition, implying unknown kinases/modifications), and transparent disease framing. Blind spots: nearly all causal evidence derives from HeLa/CHO/mouse fibroblast culture and overexpression or depletion approaches—RNAi off-targets and overexpression artifacts are unaddressed; disease-to-mitosis causal chains are largely correlative (e.g., lamin B2 overexpression promotes tumors but no study demonstrates mitotic defects cause it; the authors concede this). Cross-species extrapolation is flagged inconsistently. The review is appropriately skeptical where evidence is thin (microcephaly mechanisms) but sometimes uses 'suggesting a possible mechanism' language that risks over-weighting weak links. No quantitative synthesis or effect-size summary is attempted, so readers cannot gauge consistency of reported phenotypes.
Key falsification targets the review itself names: expressing non-phosphorylatable lamin B1 in human cells (never done), identifying remaining lamin kinases/phosphatases, and directly testing whether lamin misregulation causes aneuploidy in tumors. Negative results on these would substantially weaken the central spindle-matrix model.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.